1. Home
  2. BYFC vs RFL Comparison

BYFC vs RFL Comparison

Compare BYFC & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadway Financial Corporation

BYFC

Broadway Financial Corporation

HOLD

Current Price

$7.48

Market Cap

71.7M

Sector

Finance

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$1.29

Market Cap

63.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BYFC
RFL
Founded
1946
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Real Estate
Sector
Finance
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
71.7M
63.5M
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
BYFC
RFL
Price
$7.48
$1.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.5K
57.2K
Earning Date
04-27-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.28
EPS
N/A
N/A
Revenue
$184,000.00
$917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.71
43.96
52 Week Low
$5.51
$1.12
52 Week High
$8.85
$3.19

Technical Indicators

Market Signals
Indicator
BYFC
RFL
Relative Strength Index (RSI) 38.21 48.29
Support Level $7.19 $1.15
Resistance Level $7.54 $1.32
Average True Range (ATR) 0.10 0.07
MACD -0.05 -0.01
Stochastic Oscillator 26.46 31.66

Price Performance

Historical Comparison
BYFC
RFL

About BYFC Broadway Financial Corporation

Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: